Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-18 Purchase | 2021-11-19 1:21 pm | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 15,700 | $12.74 | $200,018 | 15,700 (Indirect) | View |
| 2021-11-16 Purchase | 2021-11-18 5:00 pm | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 7,500 | $28.08 | $210,600 | 7,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-17 Option Award | 2024-06-20 4:35 pm | N/A 2034-06-16 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A 2034-03-26 | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 44,024 | $3.83 | 44,024 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:22 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:41 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 139,355 | $0 | 221,886 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 7:30 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 49,000 | $0 | 49,000 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 66,831 | $0 | 82,531 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 42,191 | $0 | 42,191 (Direct) | View |
Ownership | 2021-10-07 9:00 pm | N/A 2031-08-18 | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 0 | $0 | 15,725 (Direct) | View |
| 2021-09-07 Option Award | 2021-09-09 5:06 pm | N/A 2031-09-07 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 42,000 | $0 | 42,000 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:21 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 68,971 | $38 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:21 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 480,000 | $0 | 0 (Direct) | View |
| 2021-04-09 Tax Withholding | 2021-04-13 1:05 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 11,088 | $37.94 | 68,971 (Direct) | View |
| 2020-04-13 Option Award | 2020-04-14 4:38 pm | N/A 2030-04-12 | FIVE PRIME THERAPEUTICS INC. | FPRX | Civik Thomas President and CEO | 555,000 | $0 | 555,000 (Direct) | View |